(Q46223882)

20 December 2017

title

Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project (English)

1 reference

20 December 2017

1 reference

Hiroshi Ishii

1

1 reference

20 December 2017

Hiroyasu Ishikawa

2

1 reference

20 December 2017

Kenichi Meguro

3

1 reference

20 December 2017

Manabu Tashiro

4

1 reference

20 December 2017

Satoshi Yamaguchi

5

1 reference

20 December 2017

publication date

1 December 2008

1 reference

20 December 2017

International Psychogeriatrics

published in

1 reference

20 December 2017

volume

21

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

148-156

1 reference

20 December 2017

Mild cognitive impairment represents early-stage Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Incidence of dementia and associated risk factors in Japan: The Osaki-Tajiri Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Prevalence and cognitive performances of clinical dementia rating 0.5 and mild cognitive impairment in Japan. The Tajiri project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Prevalence of dementia and dementing diseases in Japan: the Tajiri project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia.

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS1041610208008132

21 January 2018

https://api.crossref.org/works/10.1017%2FS1041610208008132

inferred from DOI database lookup

7 January 2021

based on heuristic

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

Aging, memory, and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610208008132

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S1041610208008132

1 reference

20 December 2017

PubMed ID

19040787

1 reference

20 December 2017